APA

McCormick L. M., Hoole S. P., White P. A., Read P. A., Axell R. G., Clarke S. J., O'Sullivan M., West N. E. J. & Dutka D. P. (20160126). Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. : JACC. Cardiovascular interventions.

Chicago

McCormick Liam M, Hoole Stephen P, White Paul A, Read Philip A, Axell Richard G, Clarke Sophie J, O'Sullivan Michael, West Nick E J and Dutka David P. 20160126. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. : JACC. Cardiovascular interventions.

Harvard

McCormick L. M., Hoole S. P., White P. A., Read P. A., Axell R. G., Clarke S. J., O'Sullivan M., West N. E. J. and Dutka D. P. (20160126). Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. : JACC. Cardiovascular interventions.

MLA

McCormick Liam M, Hoole Stephen P, White Paul A, Read Philip A, Axell Richard G, Clarke Sophie J, O'Sullivan Michael, West Nick E J and Dutka David P. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. : JACC. Cardiovascular interventions. 20160126.